PE/Cyanine5.5 Anti-Human CD47 Antibody[CC2C6D4]

Introducing the PE/Cyanine5 Anti-Human CD47 Antibody [CC2C6D4], a cutting-edge product designed to target and neutralize the CD47 protein in human cells. This antibody is meticulously engineered to bind to the CD47 antigen, which is known to play a pivotal role in immune evasion and cancer progression. With its exceptional specificity and sensitivity, this antibody is an indispensable tool for researchers and clinicians who are investigating the role of CD47 in various disease states and developing novel therapeutic strategies.

The PE/Cyanine5 conjugation provides outstanding fluorescence properties, making it an ideal choice for flow cytometry and other imaging applications. This antibody is rigorously tested and validated to ensure consistent and reproducible results, and is available in various sizes to meet the needs of different experimental setups. The PE/Cyanine5 Anti-Human CD47 Antibody [CC2C6D4] is a highly effective and reliable product that you can trust for your research and diagnostic needs.

The PE/CYANINE5 Anti-Human CD47 Antibody [CC2C6D4] is a highly specific monoclonal antibody that targets the CD47 protein found on the surface of human cells. This antibody is conjugated with both PE and CYANINE5, which allows for easy detection and analysis of CD47 expression in flow cytometry experiments. The antibody has been extensively validated for use in research applications, including immunohistochemistry, western blotting, and ELISA.

CD47 is a transmembrane protein that plays a critical role in regulating immune responses and cell signaling pathways. It is expressed on a wide range of human cells, including red blood cells, platelets, and various types of cancer cells. The PE/CYANINE5 Anti-Human CD47 Antibody [CC2C6D4] binds specifically to the extracellular domain of CD47, blocking its interaction with the SIRPα receptor on macrophages and other immune cells. This blockade can enhance phagocytosis of cancer cells and other targets, making the antibody a promising candidate for cancer immunotherapy.

The PE/CYANINE5 Anti-Human CD47 Antibody [CC2C6D4] is a valuable tool for researchers studying the role of CD47 in cancer and other diseases. Its high specificity and sensitivity make it ideal for use in a variety of applications, including flow cytometry, western blotting, and immunohistochemistry. The antibody is available in a range of sizes and formats, making it easy to incorporate into any research project. With its ability to block CD47 signaling and enhance immune responses, this antibody has the potential to revolutionize cancer treatment and other therapeutic applications.